- Home
- APM vs MTEX Comparison
APM vs MTEX Comparison
Compare APM & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APM
- MTEX
- Stock Information
- Founded
- APM 2010
- MTEX 1993
- Country
- APM United Kingdom
- MTEX United States
- Employees
- APM N/A
- MTEX N/A
- Industry
- APM Biotechnology: Pharmaceutical Preparations
- MTEX Medicinal Chemicals and Botanical Products
- Sector
- APM Health Care
- MTEX Health Care
- Exchange
- APM Nasdaq
- MTEX Nasdaq
- Market Cap
- APM 18.9M
- MTEX 15.8M
- IPO Year
- APM 2018
- MTEX 1999
- Fundamental
- Price
- APM $1.55
- MTEX $8.72
- Analyst Decision
- APM
- MTEX
- Analyst Count
- APM 0
- MTEX 0
- Target Price
- APM N/A
- MTEX N/A
- AVG Volume (30 Days)
- APM 399.9K
- MTEX 49.2K
- Earning Date
- APM 04-30-2025
- MTEX 11-11-2025
- Dividend Yield
- APM N/A
- MTEX N/A
- EPS Growth
- APM N/A
- MTEX N/A
- EPS
- APM N/A
- MTEX N/A
- Revenue
- APM N/A
- MTEX $112,975,000.00
- Revenue This Year
- APM N/A
- MTEX N/A
- Revenue Next Year
- APM N/A
- MTEX N/A
- P/E Ratio
- APM N/A
- MTEX N/A
- Revenue Growth
- APM N/A
- MTEX N/A
- 52 Week Low
- APM $0.46
- MTEX $7.22
- 52 Week High
- APM $7.49
- MTEX $16.49
- Technical
- Relative Strength Index (RSI)
- APM 41.19
- MTEX 48.19
- Support Level
- APM $1.41
- MTEX $8.60
- Resistance Level
- APM $1.63
- MTEX $12.00
- Average True Range (ATR)
- APM 0.28
- MTEX 0.80
- MACD
- APM -0.08
- MTEX -0.01
- Stochastic Oscillator
- APM 11.87
- MTEX 10.41
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.